Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated 'enemy'?
- Resource Type
- Text
- Source
- Clinical and Molecular Hepatology. 26(4):582-583
- Subject
Letter to the Editor - Language